AEZS - Spark Newswire

1 minute read

AEterna Zentaris Q3 EPS $(0.01) Up From $(0.02) YoY, Sales $600.00K Up From $128.00K YoY

Today, 11:31 PM

AEterna Zentaris (NASDAQ:AEZS) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported $600.00 thousand in

AEZS

7 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 25, 2021

By Benzinga Insights

Today, 11:31 PM

AEZS

1 minute read

HC Wainwright & Co. Initiates Coverage On AEterna Zentaris with Buy Rating, Announces Price Target of $2

By Benzinga Newsdesk

Today, 11:31 PM

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on AEterna Zentaris (NASDAQ:AEZS) with a Buy rating and announces Price Target of $2.

AEZS

3 minute read

35 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 11:31 PM

Gainers Biomerica, Inc. (NASDAQ: BMRA) shares climbed 38.3% to $6.23. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.

ADGI

1 minute read

AEterna Zentaris Q2 Sales $600.00K Up From $68.00K YoY

By Benzinga Newsdesk

Today, 11:31 PM

AEterna Zentaris (NASDAQ:AEZS) reported $600.00 thousand in sales this quarter. This is a 782.35 percent increase over sales of $68.00 thousand the same period last year.

AEZS

6 minute read

98 Biotechnology Stocks Moving In Wednesday’s Session

By Benzinga Newsdesk

Today, 11:31 PM

Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock increased by 131.7% to $3.36 during Wednesday’s regular session. • Genprex, Inc.…

ACRS

Feed Symbols: AEZS

AEterna Zentaris Q3 EPS $(0.01) Up From $(0.02) YoY, Sales $600.00K Up From $128.00K YoY

Benzinga’s Top Ratings Upgrades, Downgrades For October 25, 2021

HC Wainwright & Co. Initiates Coverage On AEterna Zentaris with Buy Rating, Announces Price Target of $2

35 Stocks Moving In Friday’s Mid-Day Session

AEterna Zentaris Q2 Sales $600.00K Up From $68.00K YoY

98 Biotechnology Stocks Moving In Wednesday’s Session